D. Huertas

发表

Generation and Characterization of Rat and Mouse Monoclonal Antibodies Specific for MeCP2 and Their Use in X-Inactivation Studies

M. Esteller, E. Kremmer, H. Leonhardt, 2011, PloS one.

Inhibition of Gsk3b Reduces Nfkb1 Signaling and Rescues Synaptic Activity to Improve the Rett Syndrome Phenotype in Mecp2-Knockout Mice.

M. Esteller, S. Guil, C. Casal, 2018, Cell reports.

Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor

M. Esteller, A. Vidal, A. Pujol, 2014, Neuropsychopharmacology.

Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model

M. Esteller, S. Sayols, J. Sandoval, 2013, RNA biology.

Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome

M. Esteller, C. Croce, G. Calin, 2010, Epigenetics.

Mutations in JMJD1C are involved in Rett syndrome and intellectual disability

M. Esteller, J. Gelpí, C. Lázaro, 2015, Genetics in Medicine.

Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues

Thomas Lengauer, M. Esteller, H. Stunnenberg, 2012, Epigenetics.

Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient

M. Esteller, J. Dopazo, I. Medina, 2012, Epigenetics.

Chromatin dynamics coupled to DNA repair

P. Muñoz, R. Sendra, D. Huertas, 2009, Epigenetics.

Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype

M. Esteller, J. Dopazo, J. Armstrong, 2016, Human Genetics.

Aberrant epigenetic landscape in intellectual disability.

M. Esteller, J. Sanchez-Mut, D. Huertas, 2012, Progress in brain research.

An increase in MECP2 dosage impairs neural tube formation

M. Esteller, N. Akizu, Alejandra García, 2014, Neurobiology of Disease.

Circadian Cycle-Dependent MeCP2 and Brain Chromatin Changes

M. Esteller, J. Ausió, J. Sanchez-Mut, 2015, PloS one.

Cancer Therapy : Preclinical Lurbinectedin ( PM 01183 ) , a New DNA Minor Groove Binder , Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

M. Esteller, M. Pujana, G. Capellá, 2012 .

Lurbinectedin ( PM 01183 ) , a New DNA Minor Groove Binder , Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

M. Esteller, M. Pujana, G. Capellá, 2012 .

Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin

M. Esteller, S. Patel, A. Villanueva, 2011, Oncogene.

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

M. Esteller, M. Pujana, G. Capellá, 2012, Clinical Cancer Research.